Lux Capital Bio
Lux Capital's bio practice
VC
Sector Specialist
📍 New York, NY
Founded 2014
AUM
$1.0B
as of 2026-07
SMALL
Lux Capital Bio is the dedicated bio practice within Lux Capital, focused on synthetic biology, computational drug discovery, and bio-platform companies.
Notable Partners
Adam GoulburnZavain Dar
Investment Focus
Stages
Series A · Series B
Sectors
Bio · Synthetic Biology
VCBio SpecialistLux Family
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2026-07. Refreshed periodically.